drugset / Trial / NCT03630198

Pain Outcomes Following Intralesional Corticosteroid Injections

NCT03630198

Phase 4 Completed 31 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

Corticosteroid therapy, including intralesional and topical applications, has many indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However, these injections can be quite painful, which leads many patients to discontinue treatment. Often, the injection involves a mixture of local anesthetic and corticosteroids despite a lack of evidence that the use of lidocaine improves pain. Due to the acidic pH, the lidocaine component of the injection can actually cause a significant burning sensation during the procedure. Lidocaine does not have anti-inflammatory properties and does not treat the underlying pathology. By including another medication, lidocaine also adds cost and risk to the procedure. The purpose of this study is to see if removing lidocaine from intralesional injections decreases the pain of injection.

Timeline

Start
2018-10-01
Primary completion
2019-09-01
Completion
2019-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified Other
Comparator Triamcinolone Acetonide Other / unclassified Other